secwatch.observer — SEC 8-K summary
======================================

Issuer:     Paysign, Inc. (PAYS)
CIK:        0001496443
Form:       8-K
Filed at:   2025-03-25T23:59:59+00:00
Accession:  0001683168-25-001858
Event type: m_and_a
Sentiment:  positive
Materiality: 0.90
Item codes: 2.02, 3.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud

Paysign Reports FY2024 Revenue of $58.38M and Acquires Gamma Innovation Assets
------------------------------------------------------------------------------

- Full-year 2024 total revenues increased 23.5% to $58.38 million, with pharma patient affordability revenue up 214.5%.
- Full-year 2024 net income was $3.82 million ($0.07 per diluted share), down from $6.46 million in 2023 due to prior year tax benefit.
- Adjusted EBITDA rose 43.3% to $9.62 million, or $0.17 per diluted share, in 2024.
- Acquired assets of Gamma Innovation LLC for cash and 2.5M restricted shares vesting over four years, plus up to 500K earn-out shares.
- Appointed Michael Ngo, former Gamma managing member, as Chief Innovation Officer.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1496443/000168316825001858/0001683168-25-001858-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1496443/000168316825001858/paysign_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-25-001858

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer